摘要
卵泡刺激素(follicle-stimulating hormone,FSH)抗体阻断FSH与破骨细胞或/和脂肪细胞的FSH受体结合,抑制破骨细胞骨吸收和促进骨形成而预防骨丢失,诱导脂肪细胞线粒体密度增加、白色脂肪米色化和激活棕色脂肪组织产热增加而降低体脂。FSH抗体有望成为同时预防骨质疏松和肥胖的潜在药物。
The follicle-stimulating hormone (FSH) antibody blocks FSH binding to FSH receptors of osteoclasts and/or adipoeytes to prevent bone loss by inhibiting bone resorption and stimulating bone formation, and reduce body fat by inducing an increase in mitochondrial density of adipoeytes, beiging of white adipocytes, and increasing thermogenesis in brown adipose tissue. FSH antibody is expected to become a potential drug for preventing osteoporosis and obesity at the same time.
作者
伍西羽
廖二元
肖业
WU Xi-yu;LIAO Er-yuan;XIAO Ye(National Clinical Research Center for Metabolic Diseases,Institute of Metabolism and Endocrinology,The Second Xiangya Hospital,Central South University,Changsha 410011,China)
出处
《中华骨质疏松和骨矿盐疾病杂志》
CSCD
北大核心
2018年第5期496-502,共7页
Chinese Journal Of Osteoporosis And Bone Mineral Research
基金
国家自然科学基金(81500685)
关键词
卵泡刺激素
卵泡刺激素抗体
骨质疏松
肥胖
follicle-stimulating hormone
follicle-stimulating hormone antibody
osteoporosis
obesity